Conditions: GastroEsophageal Cancer; Gastric Cancer
Interventions: Drug: Neratinib; Drug: Trastuzumab; Drug: Oxaliplatin; Drug: 5-Fluorouracil + leucovorin; Drug: Pembrolizumab
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Puma Biotechnology, Inc.; National Comprehensive Cancer Network
**RECRUITING NOW**
Interventions: Drug: Neratinib; Drug: Trastuzumab; Drug: Oxaliplatin; Drug: 5-Fluorouracil + leucovorin; Drug: Pembrolizumab
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Puma Biotechnology, Inc.; National Comprehensive Cancer Network
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
